Viewing Study NCT05506605


Ignite Creation Date: 2025-12-25 @ 3:29 AM
Ignite Modification Date: 2025-12-26 @ 2:10 AM
Study NCT ID: NCT05506605
Status: UNKNOWN
Last Update Posted: 2023-09-21
First Post: 2022-07-22
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Switch Strategy From Etravirine (ETR) to Doravirine (DOR) in Virologically-Suppressed HIV-1 Infected Adults With ETR-Resistance
Sponsor: Fundacion Clinic per a la Recerca Biomédica
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module